PCAR-019 (anti-CD19 CAR-T cells)
PG-019-001
Phase 2 mab active
Quick answer
PCAR-019 (anti-CD19 CAR-T cells) for Acute Lymphocytic Leukemia is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Acute Lymphocytic Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- active